Love this application of GPT!

Congratulations to the 40 researchers from Memorial Sloan Kettering Cancer Center and the Sloan Kettering Institute who are recognized on this year’s list of Clarivate 2023 Highly Cited Researchers. Learn more: bit.ly/3G5vxLe

They need to create a Pulitzer category for headlines just for whoever wrote this.

Ahmet Zehir recommends that BLOODPAC audience reads Caitlyn Vlasschaert Matt Lanktree | #NephroGenetics Michael Rauh & Pradeep Natarajan's recent #CHIP review paper in Nature Reviews Nephrology nature.com/articles/s4158…

From New York Times Opinion “Long Covid is a physical affliction, but chronic illness, stretching over months and years, has a way of picking apart your mind and breaking your heart,” writes Giorgia Lupi, who has been living with the condition for over three years. nyti.ms/48j5g8A

Our annual meeting serves everyone best if our speakers and panels address concerns our membership faces in daily practice. As you get ready to kick back and celebrate the start of the new year, let us know what we can program for you!!

If you're interested in representing the informatics subdivision across various committees please reach out! I'd be happy to give you more information and help with the application 🧬💻📊

Very excited to share our new paper on how mutations in SWI/SNF chromatin remodeling complexes alter chromatin dynamics and immune cell-fate to drive lymphoma, online now in Cancer Cell. authors.elsevier.com/c/1ijJ05TA51hO… More details in the thread below.👇 🧵 1/n

Join Natera at AACR's Annual Meeting next week. Stop by by booth #1011 and attend our oral presentation and posters showcasing our #ctDNA data in pan-cancer and colorectal cancer. ow.ly/59H450R6VaF #AACR24 #Natera #CRCResearch #Signatera

You’re telling me I’m paying nyc rent prices just to be on the same tectonic plate as Philly and Boston? I’m feeling sick

Excited to attend #AACR2024 to catch up with the latest science in oncology and friends. Reach out if you want to talk about what we are up to at Natera Oncology. We’re hiring for various positions in my group. Let’s chat!

Our latest paper out Nature Genetics today. Even more mutated genes driving clonal expansions in blood as we age. Additional genes found in UKBIOBANK UKBIOBANK confirmed in >10,000 while genomes of blood cell colonies. Calico Wellcome Sanger Institute Cambridge Stem Cell Institute Mike Spencer Chapman

How do mismatch repair-deficient (MMRd) cancers trade off the evolutionary costs and benefits of elevated mutation rates? Delighted to share our paper on adaptive mutability in MMRd colorectal cancer (CRC) Nature Genetics nature.com/articles/s4158… Tweetorial 🧵below

Retrospective study from Natera and Gregory Botta in The Oncologist Association of personalized and tumor-informed ctDNA with patient survival outcomes in #PancreaticCancer academic.oup.com/oncolo/advance… "In multivariate analysis, ctDNA detection at surveillance was found to be

This show. It’s always this show.

On behalf of the American people, I thank Joe Biden for his extraordinary leadership as President of the United States and for his decades of service to our country. I am honored to have the President’s endorsement and my intention is to earn and win this nomination.

📉 New Signatera data published in European Urology reinforces the clinical utility of #ctDNA in bladder cancer. #Urology #BladderCancer #Signatera #Natera Review the publication 👉ow.ly/f4vn50T2hls

#Natera will present new data on its personalized and tumor-informed molecular residual disease (#MRD) test, #Signatera, at ESMO - Eur. Oncology #ESMO24 Congress taking place Sept. 13-16 in Barcelona, Spain. Read more in our press release: ow.ly/H4bL50TiOX8